Search results
Results from the WOW.Com Content Network
In 1920, United Drug Company challenged the Aspirin trademark, which became officially generic for public sale in the U.S. (although it remained trademarked when sold to wholesalers and pharmacists). With demand growing rapidly in the wake of the Spanish flu, there were soon hundreds of "aspirin" brands on sale in the United States. [3]: 151–152
Aspirin is also used long-term to help prevent further heart attacks, ischaemic strokes, and blood clots in people at high risk. [11] For pain or fever, effects typically begin within 30 minutes. [11] Aspirin works similarly to other NSAIDs but also suppresses the normal functioning of platelets. [11] One common adverse effect is an upset ...
The Ebers Papyrus – one of the most important medical papyri of ancient Egypt – was written around 1550 BCE, and covers more than 700 drugs, mainly of plant origin. [7] The first references to pills were found on papyri in ancient Egypt, and contained bread dough, honey, or grease.
For premium support please call: 800-290-4726 more ways to reach us
However, Ponce's 1513 expedition to Florida was the first open and official one. He also gave Florida its name, which means "full of flowers". [18] A dubious legend states that Ponce de León was searching for the Fountain of Youth on the island of Bimini, based on information from natives. [19] [20]
Heinrich Dreser, 1897. Heinrich Dreser (1 October 1860 – 21 December 1924) was a German chemist responsible for the aspirin and heroin projects at Bayer AG.He was also a key figure in creating the widely used modern drug codeine.
Parts of an ancient shipwreck emerged from the sand at the 3200 Block of Daytona Beach Shores earlier this week, located about 5 miles south of downtown Daytona Beach, Florida. "The ocean gives us ...
By 1915, the price of phenol rose to the point that Bayer's aspirin plant was forced to drastically cut production; this was especially problematic because Bayer was instituting a new branding strategy in anticipation of the expiry of the aspirin patent in the United States.